Site US10167 University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania

Site US10167 University of Pittsburgh Medical Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Site US10167 University of Pittsburgh Medical Center has participated in 1 clinical trials.

Therapeutic areas: Urinary Bladder Overactive, Urinary Bladder Diseases\Urologic Diseases, Overactive Bladder.

Sponsors: Astellas Pharma Europe B.V..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10167 University of Pittsburgh Medical Center?

Site US10167 University of Pittsburgh Medical Center has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10167 University of Pittsburgh Medical Center conducted?

Site US10167 University of Pittsburgh Medical Center has 1 clinical trials on record. Their work covers Urinary Bladder Overactive, Urinary Bladder Diseases\Urologic Diseases, Overactive Bladder.

Is Site US10167 University of Pittsburgh Medical Center accredited by Crixeo Clinical Trials?

Site US10167 University of Pittsburgh Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10167 University of Pittsburgh Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.